Innovation rules the week at MedCity News — Weekend Rounds, June 5, 2009
Innovation in medical devices. Innovation in vaccines. Even innovation in regulating drug development -- MedCity News saw it all last week.
Innovation in medical devices. Innovation in vaccines. Even innovation in regulating drug development -- MedCity News saw it all last week.
Medtronic on Tuesday announced its acquisition of glucose-monitoring technology from the Denmark-based PreciSense. The Minnesota medical device giant will need help from its smaller, high-growth sectors like diabetes if it wants to achieve sales and revenue projections.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.